<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Signal transduction initiated by binding of antibodies to cell surface molecules can have an important impact on the growth of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>The malignant behavior of the murine <z:hpo ids='HP_0002665'>lymphoma</z:hpo> BCL1 can be suppressed and the neoplastic cells can be induced to enter a dormant state by in vivo ligation of membrane immunoglobulin </plain></SENT>
<SENT sid="2" pm="."><plain>Anti-CD19 antibodies can prolong the survival of <z:mp ids='MP_0002536'>SCID</z:mp> mice challenged with the human Burkitt <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell line, Daudi </plain></SENT>
<SENT sid="3" pm="."><plain>Here, we show that cross-linking of membrane immunoglobulin on both murine BCL1 and human Daudi cells initiates a cascade of signals leading to the induction of both <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and cell cycle arrest in vitro </plain></SENT>
<SENT sid="4" pm="."><plain>Using antisense oligonucleotides, we demonstrate that the immunoglobulin-associated Lyn tyrosine kinase is required for anti-immunoglobulin-mediated cell cycle arrest but is not required for the signal leading to <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="5" pm="."><plain>These results define a branch point in the cytosolic signaling pathways mediating cell cycle arrest and <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>In Daudi cells, Lyn is also critical for cell cycle arrest induced by anti-CD19 signaling </plain></SENT>
<SENT sid="7" pm="."><plain>Thus, the Lyn tyrosine kinase may be an important mediator of cell cycle arrest in neoplastic B lymphocytes and, perhaps, other cell types </plain></SENT>
</text></document>